Evidence map›Paper›PMID 39422777›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors.

Keishiro Izumi, Tomokazu Iyoda, Atsuko Yokota, Masahito Kanno, Masahiro Hoshi, Emi Tokuda, Eisaku Sasaki, Kenya Kanazawa, Junko Kuroda, Shigehira Saji

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keishiro IzumiClinical Oncology Center, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Tomokazu IyodaClinical Oncology Center, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Atsuko YokotaDepartment of Pharmacy, Tochigi Cancer Center, Utsunomiya City, 4-9-13 Yonan, Tochigi, Japan.
Masahito KannoDepartment of Pharmacy, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Masahiro HoshiDepartment of Pharmacy, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Emi TokudaDepartment of Medical Oncology, Fukushima Medical University, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Eisaku SasakiDepartment of Medical Oncology, Fukushima Medical University, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Kenya KanazawaClinical Oncology Center, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Junko KurodaDepartment of Pharmacy, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan.
Shigehira SajiClinical Oncology Center, Fukushima Medical University Hospital, Fukushima City, 1 Hikarigaoka, Fukushima, Japan. ss-saji@wa2.so-net.ne.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe usefulness of urine dipstick tests (UDTs) in patients with diabetes has been reported. The aim of the present study was to investigate the utility of self-performed UDTs and patient diaries in the management of impaired glucose tolerance, one of the adverse events of immune checkpoint inhibitors (ICIs).

methodsPatients receiving ICIs underwent self-checks with UDTs twice a week for up to 6 months. Pharmacists checked the results at every patient visit, and by phone every 3 months. The primary endpoint was to prospectively assess whether symptoms recorded in patient diaries and UDTs could reduce unscheduled hospital admissions due to impaired glucose tolerance. The secondary endpoint was the correlation between the symptoms in the patient diaries and UDT results.

resultsA total of 112 patients were enrolled in the study. Out of the 3197 planned self-UDTs, 3128 (97.8%) were performed. Forty-four patients (39.3%) were admitted to the hospital, two (1.8%) of whom were admitted due to abnormal glucose tolerance, with one having a positive UDT. There were 46 unscheduled outpatient visits (41.1%), of which five (4.5%) were due to abnormal glucose tolerance symptoms and four were due to a positive UDT. The correlation between descriptions of fatigue or dry mouth in the patient diaries and positive glucose UDTs was 52.4% in sensitivity and 62.4% in specificity.

conclusionSelf-monitoring of symptoms and self-performing of UDTs could not reduce the emergency hospitalization rate. However, this approach could be effective in the objective monitoring of patient status, especially regarding glucose intolerance occurrences.

Indexed as

Immune Checkpoint InhibitorsAdultAgedAged, 80 and overFemaleGlucose IntoleranceHumansMaleMiddle AgedNeoplasmsProspective StudiesUrinalysisImmune Checkpoint InhibitorsImmune checkpoint inhibitorPatient’s diaryPharmacistTelephone follow-upUrine dipstick test

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.